 TORONTO and HOUSTON, Sept. 22, 2021 GLOBE NEWSWIRE -- Medicenna Therapeutics Corp. Medicenna or the Company NASDAQ: MDNA TSX: MDNA, a clinical stage immuno-oncology company, today announced that members of its leadership team will participate in the Next-Gen Cytokine Therapeutics Summit today. 